Uddannelse
Cardiovascular management in patients with Fabry disease
Management in Patients with Fabry Disease.
Personalized approach in T2D is key for success
The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.
Multiple sclerosis progression: time for a new mechanism-driven framework
Paper by Tanja Kuhlmann et al.